Related Experiment Video
Updated: Dec 26, 2025

Author Spotlight: Oxygen-Independent Assays to Measure Mitochondrial Function in Mammals
Published on: May 19, 2023
Mitochondrial division inhibitor (mdivi-1) decreases oxidative metabolism in cancer
Wenting Dai1, Guan Wang1, Jason Chwa1
1Department of Molecular and Cellular Endocrinology, Diabetes and Metabolism Research Institute, City of Hope Medical Center, Duarte, CA, 91010, USA.
Background:
Previous studies suggested that mdivi-1 (mitochondrial division inhibitor), a putative inhibitor of dynamin-related protein (DRP1), decreased cancer cell proliferation through inducing mitochondrial fusion and altering oxygen consumption. However, the metabolic reprogramming underlying the DRP1 inhibition is still unclear in cancer cells.
Methods:
To better understand the metabolic effect of DRP1 inhibition, [U-13C]glucose isotope tracing was employed to assess mdivi-1 effects in several cancer cell lines, DRP1-WT (wild-type) and DRP1-KO (knockout) H460 lung cancer cells and mouse embryonic fibroblasts (MEFs).
Results:
Mitochondrial staining confirmed that mdivi-1 treatment and DRP1 deficiency induced mitochondrial fusion. Surprisingly, metabolic isotope tracing found that mdivi-1 decreased mitochondrial oxidative metabolism in the lung cancer cell lines H460, A549 and the colon cancer cell line HCT116. [U-13C]glucose tracing studies also showed that the TCA cycle intermediates had significantly lower enrichment in mdivi-1-treated cells. In comparison, DRP1-WT and DRP1-KO H460 cells had similar oxidative metabolism, which was decreased by mdivi-1 treatment. Furthermore, mdivi-1-mediated effects on oxidative metabolism were independent of mitochondrial fusion.
Conclusions:
Our data suggest that, in cancer cells, mdivi-1, a putative inhibitor of DRP1, decreases oxidative metabolism to impair cell proliferation.
Insights
Mdivi-1, a dynamin-related protein 1 (DRP1) inhibitor, reduces cancer cell oxidative metabolism and proliferation. This effect occurs independently of mitochondrial fusion, suggesting a novel therapeutic strategy for cancer treatment.
Area of Science:
- Mitochondrial biology
- Cancer metabolism
- Cellular respiration
Background:
- Dynamin-related protein 1 (DRP1) regulates mitochondrial dynamics.
- Mdivi-1, a DRP1 inhibitor, was previously shown to decrease cancer cell proliferation.
- The precise metabolic reprogramming induced by DRP1 inhibition in cancer cells remains poorly understood.
Purpose of the Study:
- To investigate the metabolic effects of DRP1 inhibition by mdivi-1 in various cancer cell lines.
- To elucidate the role of mitochondrial dynamics in mediating mdivi-1's metabolic impact.
Main Methods:
- Utilized [U-13C]glucose isotope tracing to analyze metabolic flux.
- Assessed mdivi-1 effects in DRP1-WT and DRP1-KO H460 lung cancer cells and mouse embryonic fibroblasts (MEFs).
- Confirmed mitochondrial morphology changes using mitochondrial staining.
Main Results:
- Mdivi-1 treatment and DRP1 deficiency induced mitochondrial fusion.
- Metabolic isotope tracing revealed decreased mitochondrial oxidative metabolism in mdivi-1-treated cancer cells (H460, A549, HCT116).
- TCA cycle intermediates showed significantly lower enrichment in mdivi-1-treated cells, independent of mitochondrial fusion.
Conclusions:
- Mdivi-1, a DRP1 inhibitor, decreases oxidative metabolism in cancer cells.
- This reduction in oxidative metabolism contributes to impaired cancer cell proliferation.
- DRP1 inhibition represents a potential therapeutic avenue for targeting cancer cell metabolism.
Related Concept Videos
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Mitochondrial Membranes
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Molecular Factors Affecting Cell Division
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...
Inhibition of Cdk Activity
Mitochondria

